Sierra Oncology, Inc

(NASDAQ:SRRA)

Latest On Sierra Oncology, Inc (SRRA):

Date/Time Type Description Signal Details
2022-05-06 07:46 ESTNewsSierra Oncology GAAP EPS of -$1.33 misses by $0.30N/A
2022-04-19 11:05 ESTNewsGlaxoSmithKline's Acquisition Of Sierra Oncology Improves Relations With Activist ElliottN/A
2022-04-13 23:00 ESTNewsHot Stocks: Travel stocks rally; SRRA, ATRS jump on merger deals; NSTG plunges; BCYC extends lowN/A
2022-04-13 07:46 ESTNewsGSK to acquire Sierra Oncology for $1.9B to bolster specialty meds; Sierra soars 38%N/A
2022-03-10 22:05 ESTNewsSierra Oncology Non-GAAP EPS of -$1.44N/A
2022-02-03 17:44 ESTNewsSierra Oncology raises additional funds from underwriters of stock offeringN/A
2022-01-29 06:36 ESTNewsSierra Oncology's Strong Data In Myelofibrosis Challenges MorphoSys And IncyteN/A
2022-01-27 03:32 ESTNewsSierra Oncology: Plenty Of Room To Trade Higher After Latest Myelofibrosis DataN/A
2022-01-27 03:31 ESTNewsSierra Oncology secures $135M capital via equity raiseN/A
2022-01-25 18:57 ESTNewsSierra Oncology says late-stage trial for momelotinib in myelofibrosis met key goalsN/A
2022-01-25 18:57 ESTNewsSierra Oncology hits 52-week high as shares rise 43%; trading briefly haltedN/A
2022-01-25 18:57 ESTNewsSierra Oncology plans $100M stock offeringN/A
2022-01-18 11:01 ESTNewsSierra Oncology updates on data readout for late-stage cancer candidateN/A
2021-12-03 20:54 ESTNewsSierra Oncology announces stock options to six new employeesN/A
2021-08-09 15:08 ESTNewsSierra Oncology accelerates planned filing of myelofibrosis candidate momelotinibN/A
2021-08-06 10:53 ESTNewsAstraZeneca licenses myelofibrosis candidate to Sierra OncologyN/A
2021-08-06 10:52 ESTNewsSierra Oncology EPS misses by $0.06N/A
2021-07-22 01:42 ESTNewsSierra Oncology completes enrollment in late-stage myelofibrosis studyN/A
2021-07-22 01:31 ESTNewsSizing Up Sierra OncologyN/A
2021-03-17 08:35 ESTNewsSierra Oncology (SRRA) Investor Presentation - SlideshowN/A
2021-03-12 08:35 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 04:44 ESTEarnings EstimateAn EPS average of -$4.92 is estimated for the 2022 year.Sell
2021-03-12 04:44 ESTEarnings EstimateAn EPS average of -$1.76 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-11 14:27 ESTNewsSierra Oncology EPS misses by $0.11N/A
2021-01-27 21:15 ESTNewsSierra Oncology: Time To Enter For The Big PieN/A
2020-12-18 13:03 ESTAnalyst RatingThe Analyst Target Price has increased from $27.25 to $27.75.Buy
2020-12-14 00:49 ESTAnalyst RatingThe Analyst Target Price has increased from $25 to $27.25.Buy
2020-12-11 11:59 ESTNewsSierra Oncology is a ‘Buy’ at H.C. WainwrightN/A
2020-12-08 12:24 ESTNewsSierra Oncology's momelotinib shows survival benefit in myelofibrosis studiesN/A
2020-11-26 21:39 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 05:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $26.5 to $25.Neutral
2020-11-10 13:12 ESTAnalyst RatingThe Analyst Target Price has increased from $25.5 to $26.5.Buy
2020-11-09 05:13 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 05:13 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.75 to $25.5.Neutral
2020-11-08 00:58 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 12:48 ESTEarnings EstimateAn EPS average of -$1.84 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-05 15:32 ESTNewsSierra Oncology EPS beats by $0.23N/A
2020-09-26 14:06 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:19 ESTFinancialsCompany financials have been released.Neutral
2020-09-11 09:33 ESTAnalyst RatingThe Analyst Target Price has decreased from $27.5 to $25.75.Neutral
2020-08-18 20:28 ESTInsider TradeBarbara Klencke has acquired 3,325 shares indirectly via their spouse.Buy
2020-08-18 20:28 ESTInsider TradeBarbara Klencke has directly acquired 5,950 shares and currently holds 10,000 shares.Buy
2020-08-14 10:11 ESTFinancialsCompany financials have been released.Neutral
2020-08-11 22:11 ESTAnalyst RatingThe Analyst Target Price has decreased from $29.25 to $27.5.Neutral
2020-08-10 21:55 ESTAnalyst RatingThe Analyst Target Price has decreased from $29.5 to $29.25.Neutral
2020-08-09 01:45 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 02:29 ESTNewsSierra Oncology EPS beats by $0.02N/A
2020-08-07 02:28 ESTNewsSierra Oncology files for $150M mixed shelfN/A
2020-08-06 13:59 ESTFinancialsCompany financials have been released.Neutral

About Sierra Oncology, Inc (SRRA):

Sierra Oncology, Inc. researches, develops, and commercializes therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib, is a selective and orally-bioavailable JAK1, JAK2, and ACVR1 inhibitor that has two completed Phase 3 trials for the treatment of myelofibrosis. The company also develops SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1; and SRA141, an orally bioavailable small molecule inhibitor of cell division cycle 7 kinase. The company was formerly known as ProNAi Therapeutics, Inc. and changed its name to Sierra Oncology, Inc. in January 2017. Sierra Oncology, Inc. was incorporated in 2003 and is based in San Mateo, California.

SRRA Quotes by TradingView

See Advanced Chart

General

  • Name Sierra Oncology, Inc
  • Symbol SRRA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 69
  • Last Split Factor1:40
  • Last Split Date2020-01-23
  • Fiscal Year EndDecember
  • IPO Date2015-07-16
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.sierraoncology.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 1365.38
  • Price/Book (Most Recent Quarter) 1.54
  • Enterprise Value Revenue 541.34
  • Enterprise Value EBITDA 0.16
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.18
  • Next Year EPS Estimate -$4.54
  • Operating Margin -21314%
  • Return on Assets -31%
  • Return on Equity -88%
  • Revenue 300000
  • Earnings Per Share -$0.78
  • Revenue Per Share $0.03
  • Gross Profit -44818000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 231.87 million
  • EBITDA -59330000
  • PEG Ratio -0.03
  • Analyst Target Price $27.75
  • Book Value Per Share $8.80
View More

Share Statistics

  • Shares Outstanding 11.63 million
  • Shares Float 4.44 million
  • % Held by Insiders 327%
  • % Held by Institutions 80.84%
  • Shares Short 8969
  • Shares Short Prior Month 4878
  • Short Ratio 0.48
View More

Technicals

  • Beta 1.09
  • 52 Week High $20.25
  • 52 Week Low $8.65
  • 50 Day Moving Average 15.1
  • 200 Day Moving Average 14
View More

Dividends

  • Dividend Date 2020-01-23
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Sierra Oncology, Inc (SRRA) Dividend Calendar:

SRRA's last dividend payment was made to shareholders on January 23, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Sierra Oncology, Inc (SRRA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$N/A-$1.61-$1.52-6.1%
2020-09-302020-11-05$N/A-$1.39-$1.6214.37%
2020-06-302020-08-06$N/A-$1.58-$1.601.45%
2020-03-312020-05-07$N/A-$3.14-$2.74-14.6%
2019-12-312020-03-03$N/A-$7.88-$3.17-148.97%
2019-09-302019-11-04$N/A-$6.80-$8.4019.05%
2019-06-302019-08-08$N/A-$8.00-$7.87-1.69%
2019-03-312019-05-08$N/A-$6.80-$8.4019.05%
2018-12-312019-02-28$N/A-$7.60-$9.0015.56%
2018-09-302018-11-08$N/A-$8.40-$7.40-13.51%
2018-06-302018-08-09$N/A-$6.40-$6.603.03%
2018-03-312018-05-10$N/A-$7.60-$8.6011.63%
2017-12-312018-02-27$N/A-$8.00-$8.131.64%
2017-09-302017-11-08$N/A-$7.60-$8.5310.94%
2017-06-302017-08-10$N/A-$8.00-$8.273.23%
2017-03-312017-05-09$N/A-$10.40-$8.00-30%
2016-12-312017-03-02$N/A-$12.00-$10.80-11.11%
2016-09-302016-11-10$N/A-$20.00-$11.60-72.41%
2016-06-302016-08-12$N/A-$17.20-$15.60-10.26%
2016-03-312016-05-10$N/A-$14.00-$16.0012.5%
2015-12-312016-03-03$N/A-$15.20-$28.0045.71%
2015-09-302015-11-05$N/A-$11.03-$0.48-2197.92%
2015-06-302015-07-16$N/A-$104.10-$4.42-2255.2%

Sierra Oncology, Inc (SRRA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Sierra Oncology, Inc (SRRA) Chart:

Sierra Oncology, Inc (SRRA) News:

Below you will find a list of latest news for Sierra Oncology, Inc (SRRA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Sierra Oncology, Inc (SRRA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest SRRA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST16$54.875
Jun 13, 2022 7:59 PM EST4$54.875
Jun 13, 2022 7:59 PM EST2$54.87
Jun 13, 2022 7:59 PM EST58$54.87
Jun 13, 2022 7:59 PM EST60$54.875

Sierra Oncology, Inc (SRRA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520166685/0001193125-20-166685-index.htm
2018-06-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1290149/000000000018018735/0000000000-18-018735-index.htm
2020-08-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1290149/000000000020007272/0000000000-20-007272-index.htm
2019-11-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000089924319028187/0000899243-19-028187-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000089924320002476/0000899243-20-002476-index.htm
2020-01-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000090514820000073/0000905148-20-000073-index.htm
2019-11-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000090571819000967/0000905718-19-000967-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000090571819000975/0000905718-19-000975-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000090571820000098/0000905718-20-000098-index.htm
2020-02-034/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000090571820000101/0000905718-20-000101-index.htm
2020-02-10SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1290149/000090571820000111/0000905718-20-000111-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000090571820000564/0000905718-20-000564-index.htm
2018-09-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000091957418006061/0000919574-18-006061-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000091957419001183/0000919574-19-001183-index.htm
2020-02-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000091957420000696/0000919574-20-000696-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000091957420001131/0000919574-20-001131-index.htm
2019-11-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000094787119000870/0000947871-19-000870-index.htm
2019-11-27SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1290149/000094787119000871/0000947871-19-000871-index.htm
2019-11-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000110465919067033/0001104659-19-067033-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000110465920013787/0001104659-20-013787-index.htm
2018-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000117266118000537/0001172661-18-000537-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000117266119000443/0001172661-19-000443-index.htm
2020-10-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000117266120002020/0001172661-20-002020-index.htm
2018-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000119312518042973/0001193125-18-042973-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000119312518045235/0001193125-18-045235-index.htm
2018-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312518059363/0001193125-18-059363-index.htm
2018-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1290149/000119312518059374/0001193125-18-059374-index.htm
2018-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1290149/000119312518059380/0001193125-18-059380-index.htm
2018-03-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1290149/000119312518067084/0001193125-18-067084-index.htm
2018-03-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1290149/000119312518068874/0001193125-18-068874-index.htm
2018-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312518068880/0001193125-18-068880-index.htm
2018-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1290149/000119312518127649/0001193125-18-127649-index.htm
2018-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1290149/000119312518127654/0001193125-18-127654-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312518158334/0001193125-18-158334-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1290149/000119312518158341/0001193125-18-158341-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312518193578/0001193125-18-193578-index.htm
2018-06-15S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1290149/000119312518193600/0001193125-18-193600-index.htm
2018-06-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1290149/000119312518196584/0001193125-18-196584-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312518243450/0001193125-18-243450-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1290149/000119312518243457/0001193125-18-243457-index.htm
2018-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312518254453/0001193125-18-254453-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312518321842/0001193125-18-321842-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1290149/000119312518321855/0001193125-18-321855-index.htm
2018-11-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1290149/000119312518321890/0001193125-18-321890-index.htm
2018-11-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1290149/000119312518325674/0001193125-18-325674-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000119312519038097/0001193125-19-038097-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000119312519040978/0001193125-19-040978-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519055539/0001193125-19-055539-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1290149/000119312519055556/0001193125-19-055556-index.htm
2019-02-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1290149/000119312519055563/0001193125-19-055563-index.htm
2019-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1290149/000119312519114129/0001193125-19-114129-index.htm
2019-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1290149/000119312519114133/0001193125-19-114133-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519140452/0001193125-19-140452-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1290149/000119312519140458/0001193125-19-140458-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519163365/0001193125-19-163365-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519165494/0001193125-19-165494-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519171809/0001193125-19-171809-index.htm
2019-07-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519197169/0001193125-19-197169-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519216002/0001193125-19-216002-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1290149/000119312519216008/0001193125-19-216008-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519283321/0001193125-19-283321-index.htm
2019-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1290149/000119312519283332/0001193125-19-283332-index.htm
2019-11-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1290149/000119312519285881/0001193125-19-285881-index.htm
2019-11-07S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1290149/000119312519286677/0001193125-19-286677-index.htm
2019-11-07FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1290149/000119312519286729/0001193125-19-286729-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519287465/0001193125-19-287465-index.htm
2019-11-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1290149/000119312519287472/0001193125-19-287472-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519291032/0001193125-19-291032-index.htm
2019-11-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1290149/000119312519299958/0001193125-19-299958-index.htm
2019-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312519300481/0001193125-19-300481-index.htm
2019-12-06PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1290149/000119312519307723/0001193125-19-307723-index.htm
2019-12-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1290149/000119312519316773/0001193125-19-316773-index.htm
2020-01-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520011076/0001193125-20-011076-index.htm
2020-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520012079/0001193125-20-012079-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520026139/0001193125-20-026139-index.htm
2020-02-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1290149/000119312520029811/0001193125-20-029811-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000119312520033451/0001193125-20-033451-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520059696/0001193125-20-059696-index.htm
2020-03-0310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1290149/000119312520059703/0001193125-20-059703-index.htm
2020-03-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1290149/000119312520059858/0001193125-20-059858-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520108650/0001193125-20-108650-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1290149/000119312520118148/0001193125-20-118148-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1290149/000119312520118154/0001193125-20-118154-index.htm
2020-04-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1290149/000119312520126362/0001193125-20-126362-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520135579/0001193125-20-135579-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1290149/000119312520135583/0001193125-20-135583-index.htm
2020-05-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520150818/0001193125-20-150818-index.htm
2020-05-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1290149/000119312520151595/0001193125-20-151595-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520159521/0001193125-20-159521-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520166685/0001193125-20-166685-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000119312520211286/0001193125-20-211286-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1290149/000119312520211302/0001193125-20-211302-index.htm
2020-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1290149/000119312520211355/0001193125-20-211355-index.htm
2020-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1290149/000119312520211424/0001193125-20-211424-index.htm
2020-08-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1290149/000119312520216332/0001193125-20-216332-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000119380518000218/0001193805-18-000218-index.htm
2018-02-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118008447/0001209191-18-008447-index.htm
2018-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118017777/0001209191-18-017777-index.htm
2018-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118017778/0001209191-18-017778-index.htm
2018-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118017780/0001209191-18-017780-index.htm
2018-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118017781/0001209191-18-017781-index.htm
2018-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118017783/0001209191-18-017783-index.htm
2018-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118017785/0001209191-18-017785-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118037784/0001209191-18-037784-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118037785/0001209191-18-037785-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118037787/0001209191-18-037787-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118037788/0001209191-18-037788-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118037789/0001209191-18-037789-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118037790/0001209191-18-037790-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118037795/0001209191-18-037795-index.htm
2018-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919118062056/0001209191-18-062056-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119016737/0001209191-19-016737-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119016738/0001209191-19-016738-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119016740/0001209191-19-016740-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119016742/0001209191-19-016742-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119016748/0001209191-19-016748-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119036483/0001209191-19-036483-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119036484/0001209191-19-036484-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119036485/0001209191-19-036485-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119036487/0001209191-19-036487-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119036489/0001209191-19-036489-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119036490/0001209191-19-036490-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119036491/0001209191-19-036491-index.htm
2019-08-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119047421/0001209191-19-047421-index.htm
2019-11-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119058222/0001209191-19-058222-index.htm
2019-11-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119058223/0001209191-19-058223-index.htm
2019-11-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119058224/0001209191-19-058224-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119058686/0001209191-19-058686-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119058690/0001209191-19-058690-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919119058693/0001209191-19-058693-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120005791/0001209191-20-005791-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120005792/0001209191-20-005792-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120005793/0001209191-20-005793-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120005794/0001209191-20-005794-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120013404/0001209191-20-013404-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120013406/0001209191-20-013406-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120013407/0001209191-20-013407-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120013408/0001209191-20-013408-index.htm
2020-05-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120032935/0001209191-20-032935-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120032947/0001209191-20-032947-index.htm
2020-06-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120033520/0001209191-20-033520-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120033528/0001209191-20-033528-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120035686/0001209191-20-035686-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120035687/0001209191-20-035687-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120035688/0001209191-20-035688-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120035689/0001209191-20-035689-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120035690/0001209191-20-035690-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120035691/0001209191-20-035691-index.htm
2020-07-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120043971/0001209191-20-043971-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120043972/0001209191-20-043972-index.htm
2020-08-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120045575/0001209191-20-045575-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120045576/0001209191-20-045576-index.htm
2020-08-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120046209/0001209191-20-046209-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120046213/0001209191-20-046213-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120046501/0001209191-20-046501-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120046502/0001209191-20-046502-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000120919120047352/0001209191-20-047352-index.htm
2019-11-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000121390019024633/0001213900-19-024633-index.htm
2019-12-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000121390019025159/0001213900-19-025159-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1290149/000121390020002313/0001213900-20-002313-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1290149/000121390020003598/0001213900-20-003598-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1290149/000156459020050848/0001564590-20-050848-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1290149/000156459020050865/0001564590-20-050865-index.htm
2018-06-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1290149/999999999518001576/9999999995-18-001576-index.htm
2020-08-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1290149/999999999520002142/9999999995-20-002142-index.htm
2018-11-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1290149/999999999718009196/9999999997-18-009196-index.htm

Sierra Oncology, Inc (SRRA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sierra Oncology, Inc (SRRA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 327%
Institutional Ownership: 8084%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-18Barbara KlenckeChief Development OfficerBuy5,950.0012.2272,709.6010,000.00https://www.sec.gov/Archives/edgar/data/1290149/000120919120047352/0001209191-20-047352-index.htm
2019-08-23Barbara KlenckeChief Development OfficerBuy108,000.000.4447,379.60162,000.00https://www.sec.gov/Archives/edgar/data/1290149/000120919119047421/0001209191-19-047421-index.htm
2020-08-18Barbara KlenckeChief Development OfficerBuy3,325.0012.2540,737.575,000.00https://www.sec.gov/Archives/edgar/data/1290149/000120919120047352/0001209191-20-047352-index.htm
2019-08-22Barbara KlenckeChief Development OfficerBuy54,000.000.4524,294.6054,000.00https://www.sec.gov/Archives/edgar/data/1290149/000120919119047421/0001209191-19-047421-index.htm
2018-12-10Andrew R AllenDirectorBuy66,000.001.64108,240.0066,000.00https://www.sec.gov/Archives/edgar/data/1290149/000120919118062056/0001209191-18-062056-index.htm
2019-08-22Barbara KlenckeChief Development OfficerBuy67,000.000.4328,964.1067,000.00https://www.sec.gov/Archives/edgar/data/1290149/000120919119047421/0001209191-19-047421-index.htm